相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Transient blockade of the inducible costimulator pathway generates long-term tolerance to factor VIII after nonviral gene transfer into hemophilia A mice
Baowei Peng et al.
BLOOD (2008)
Gene delivery of indoleamine 2,3-dioxygenase prolongs cardiac allograft survival by shaping the types of T-cell responses
Guang Yu et al.
JOURNAL OF GENE MEDICINE (2008)
Hernatopoietic stem-cell gene therapy of hemophilia A incorporating a porcine factor VIII transgene and nonmyeloablative conditioning regimens
Lucienne M. Ide et al.
BLOOD (2007)
Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer
Ou Cao et al.
BLOOD (2007)
Suppression of memory CD8 T cell generation and function by tryptophan catabolism
Zhiwei Liu et al.
JOURNAL OF IMMUNOLOGY (2007)
Sleeping Beauty-mediated eNOS gene therapy attenuates monocrotaline-induced pulmonary hypertension in rats
Li Liu et al.
FASEB JOURNAL (2006)
Sleeping Beauty-based gene therapy with indoleamine 2,3-dioxygenase inhibits lung allograft fibrosis
Hanzhong Liu et al.
FASEB JOURNAL (2006)
Immune deviation by mucosal antigen administration suppresses gene-transfer-induced inhibitor formation to factor IX
Ou Cao et al.
BLOOD (2006)
Immunomodulation of transgene responses following naked DNA transfer of human factor VIII into hemophilia A mice
Carol H. Miao et al.
BLOOD (2006)
Sustained expression of Epstein-Barr virus episomal vector mediated factor VIII in vivo following muscle electroporation
WH Mei et al.
HAEMOPHILIA (2006)
Sustained FVIII expression and phenotypic correction of hemophilia A in neonatal mice using an endothelial-targeted Sleeping Beauty transposon
Li Liu et al.
MOLECULAR THERAPY (2006)
Prevention of cytotoxic T lymphocyte responses to factor IX-expressing hepatocytes by gene transfer-induced regulatory T cells
E Dobrzynski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Novel action of indoleamine 2,3-dioxygenase attenuating acute lung allograft injury
HZ Liu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Hyperactive transposase mutants of the Sleeping Beauty transposon
J Baus et al.
MOLECULAR THERAPY (2005)
FIV treats hemophilia A
[Anonymous]
MOLECULAR THERAPY (2005)
Persistent expression of factor VIII in vivo following nonprimate lentiviral gene transfer
YB Kang et al.
BLOOD (2005)
Absence of a desmopressin response after therapeutic expression of factor VIII in hemophilia A dogs with liver-directed neonatal gene therapy
LF Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon system
JR Ohlfest et al.
BLOOD (2005)
FVIII gene delivery by muscle electroporation corrects murine hemophilia A
YC Long et al.
JOURNAL OF GENE MEDICINE (2005)
Immune implications of gene therapy for hemophilia
RW Herzog et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2004)
Inhibitors in hemophilia A: Mechanisms of inhibition, management and perspectives
NM Ananyeva et al.
BLOOD COAGULATION & FIBRINOLYSIS (2004)
Endothelial targeting of the Sleeping Beauty transposon within lung
L Liu et al.
MOLECULAR THERAPY (2004)
Inhibitors in congenital coagulation disorders
NS Key
BRITISH JOURNAL OF HAEMATOLOGY (2004)
IDO expression by dendritic cells: Tolerance and tryptophan catabolism
AL Mellor et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Induction of immune tolerance by neonatal intravenous injection of human factor VIII in murine hemophilia A
S Madoiwa et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Tolerance, DCs and tryptophan: much ado about IDO
U Grohmann et al.
TRENDS IN IMMUNOLOGY (2003)
Indoleamine 2,3-dioxygenase-expressing antigen-presenting cells and peripheral T-cell tolerance: Another piece to the atopic puzzle?
D von Bubnoff et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Dual vectors expressing murine factor VIII result in sustained correction of hemophilia A mice
C Mah et al.
HUMAN GENE THERAPY (2003)
CTLA-4-Ig regulates tryptophan catabolism in vivo
U Grohmann et al.
NATURE IMMUNOLOGY (2002)
T cell apoptosis by tryptophan catabolism
I Fallarino et al.
CELL DEATH AND DIFFERENTIATION (2002)
Endogenous kynurenines as targets for drug discovery and development
TW Stone et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses
AL Mellor et al.
JOURNAL OF IMMUNOLOGY (2002)
Stimulation of CD25+CD4+regulatory T cells through GITR breaks immunological self-tolerance
J Shimizu et al.
NATURE IMMUNOLOGY (2002)
Indoleamine 2,3-dioxygenase expression in trans-planted NOD islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes
AM Alexander et al.
DIABETES (2002)
Haemophilia A: effects of inhibitory antibodies on factor VIII functional interactions and approaches to prevent their action
EL Saenko et al.
HAEMOPHILIA (2002)
Control of T-cell activation by CD4+ CD25+ suppressor T cells
EM Shevach et al.
IMMUNOLOGICAL REVIEWS (2001)
Long-term induction of immune tolerance after blockade of CD40-CD40L interaction in a mouse model of hemophilia A
G Rossi et al.
BLOOD (2001)
Blockade of tryptophan catabolism prevents spontaneous tolerogenicity of liver allografts
T Miki et al.
TRANSPLANTATION PROCEEDINGS (2001)
Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogs
AM Gallo-Penn et al.
BLOOD (2001)
分享论文
